At yesterday's #GenBiology Workshop, Sarah Teichmann revealed that Ensocell, a venture-backed spinout from her lab and the Sanger Institute is looking for talented scientists to join its computational team. See below to read about two exciting opportunities based in Cambridge, UK.👇

AI covers all steps of the drug discovery pipeline across different functions from discovery and validation to the late clinical stage, says Marta Milo, describing how AI is helping AstraZeneca work towards its ambition to eliminate cancer as a cause of death. #GenBiology

Sarah Teichmann of @cambridgeuni.bsky.social describes projects to map the human body: "If we sort of dream for a minute, then one day we might be able to make whole chromosomes, inject them into cells culture and then have an entire engineered cell that has the properties that we want" #GenBiology

Today the hub is hosting our first workshop. Today's subject is #GenBiology. UCL's Chris Barnes kick's off the event with a presentation on using generative models for genome design.

In our panel discussion on the Future of Gen AI, Professor Lourdes de Agapito Vincente observes a change from the past when UK AI companies had to sell up when they reach a certain stage of development. "I am now seeing examples of companies who haven't done that so far," she notes. #GenAIHubLaunch

#GenAIHubLaunch is live! Our Director, Professor David Barber introduces the hub, following welcomes from UCL Head of Computer Science, Danny Alexander. @uclengineering.bsky.social

Our researchers are working across seven groups, each focusing on a different area of Generative AI. You can find out more about the groups and their leads on our website. www.ucl.ac.uk/ai-centre/ge...